CH399653A - Verfahren zur Inaktivierung von Poliomyelitisviren - Google Patents
Verfahren zur Inaktivierung von PoliomyelitisvirenInfo
- Publication number
- CH399653A CH399653A CH1412560A CH1412560A CH399653A CH 399653 A CH399653 A CH 399653A CH 1412560 A CH1412560 A CH 1412560A CH 1412560 A CH1412560 A CH 1412560A CH 399653 A CH399653 A CH 399653A
- Authority
- CH
- Switzerland
- Prior art keywords
- per
- chelating agent
- formaldehyde
- inactivating
- tetraacetate
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims description 19
- 238000000034 method Methods 0.000 title claims description 14
- 208000000474 Poliomyelitis Diseases 0.000 title claims description 10
- 230000000415 inactivating effect Effects 0.000 title claims description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 26
- 239000002738 chelating agent Substances 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- 230000002779 inactivation Effects 0.000 claims description 7
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 5
- 238000012360 testing method Methods 0.000 description 3
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RNMCCPMYXUKHAZ-UHFFFAOYSA-N 2-[3,3-diamino-1,2,2-tris(carboxymethyl)cyclohexyl]acetic acid Chemical compound NC1(N)CCCC(CC(O)=O)(CC(O)=O)C1(CC(O)=O)CC(O)=O RNMCCPMYXUKHAZ-UHFFFAOYSA-N 0.000 description 1
- QDHGQJQZPJPKJK-UHFFFAOYSA-N 2-[carboxymethyl-(2,4,6-trioxo-1,3-diazinan-5-yl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C1C(=O)NC(=O)NC1=O QDHGQJQZPJPKJK-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- -1 acetoacetic acid ester Chemical class 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32661—Methods of inactivation or attenuation
- C12N2770/32663—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB55993A DE1131846B (de) | 1959-12-22 | 1959-12-22 | Verfahren zur Inaktivierung von Poliomyelitisviren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH399653A true CH399653A (de) | 1965-09-30 |
Family
ID=6971173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1412560A CH399653A (de) | 1959-12-22 | 1960-12-16 | Verfahren zur Inaktivierung von Poliomyelitisviren |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE598471A (lm) |
| CH (1) | CH399653A (lm) |
| DE (1) | DE1131846B (lm) |
| FR (1) | FR1023M (lm) |
| GB (1) | GB949684A (lm) |
| SE (1) | SE309826B (lm) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1042179B (de) * | 1957-07-11 | 1958-10-30 | Pasteur Institut | Verfahren zur Herstellung antigenhaltiger Impfstoffe |
-
1959
- 1959-12-22 DE DEB55993A patent/DE1131846B/de active Pending
-
1960
- 1960-12-16 CH CH1412560A patent/CH399653A/de unknown
- 1960-12-20 GB GB43811/60A patent/GB949684A/en not_active Expired
- 1960-12-22 BE BE598471A patent/BE598471A/fr unknown
- 1960-12-22 SE SE12424/60A patent/SE309826B/xx unknown
-
1961
- 1961-03-21 FR FR856343A patent/FR1023M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR1023M (lm) | 1961-12-26 |
| BE598471A (fr) | 1961-06-22 |
| GB949684A (en) | 1964-02-19 |
| SE309826B (lm) | 1969-04-08 |
| DE1131846B (de) | 1962-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1924303A1 (de) | AEthylaethylenimin als Inaktivierungsmittel | |
| DE1924304C3 (de) | Diäthylaminoäthyldextran (DEAE-D) als Adjuvans für Impfstoffe zur aktiven Immunisierung von Säugetieren | |
| AT222274B (lm) | ||
| CH399653A (de) | Verfahren zur Inaktivierung von Poliomyelitisviren | |
| DE68917709T2 (de) | Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides. | |
| CH423095A (de) | Verfahren zur Herstellung eines Tollwutimpfstoffes | |
| DE2262427C3 (de) | Immunostimulierendes Mittel | |
| DE1492243C3 (de) | Injizierbare Impfstoffe | |
| DE2528584A1 (de) | Verfahren zur inaktivierung der virusinfektiositaet unter gleichzeitiger stabilisierung von virusantigenen | |
| DE2034118A1 (en) | Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins | |
| Glick et al. | White blood cell counts in bursectomized birds | |
| DE3877015T2 (de) | Antikoerper enthaltende stabilisierte waesserige zusammensetzung. | |
| DE2225548C3 (de) | Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis | |
| DE1246167B (de) | Verfahren zur Herstellung von Influenza-Vaccinen | |
| DE543604C (de) | Verfahren zur Dauersterilisierung von Heilseren | |
| DE324747C (de) | Verfahren zur Herstellung von Heilmittelpraeparaten aus basischen organischen Farbstoffen und Hefeeiweiss | |
| DE940315C (de) | Verfahren zur Herstellung von Lymphe gegen Schweinepest | |
| DE2340911A1 (de) | Tetanus-antigen und verfahren zu seiner herstellung | |
| DE1007473B (de) | Verfahren zur Herstellung eines Poliomyelitis-Impfstoffes | |
| AT216142B (de) | Verfahren zur Herstellung von Depotimpfstoffen | |
| CH617350A5 (en) | Process for the preparation of HB-Ag vaccines with high-level antibody formation | |
| CH430052A (de) | Verfahren zur Herstellung eines inaktivierten Pockenimpfstoffes | |
| AT200257B (lm) | ||
| DE959048C (de) | Verfahren zur Herstellung eines Impfstoffes zur aktiven Schutzimpfung gegen spinale Kinderlaehmung | |
| AT226372B (de) | Dessaggregiertes Gammaglobulin und Verfahren zu seiner Herstellung |